Literature DB >> 21352477

Motor deficits in neurofibromatosis type 1 mice: the role of the cerebellum.

T van der Vaart1, G M van Woerden, Y Elgersma, C I de Zeeuw, M Schonewille.   

Abstract

Neurofibromatosis type 1 (NF1) is an autosomal dominantly inherited disease, characterized by various neurocutaneous symptoms, cognitive impairments and problems in fine and gross motor performance. Although cognitive deficits in NF1 have been attributed to increased release of the inhibitory neurotransmitter γ-amino butyric acid (GABA) in the hippocampus, the origin of the motor deficits is unknown. Cerebellar Purkinje cells, the sole output neurons of the cerebellar cortex, are GABAergic neurons and express neurofibromin at high levels, suggesting an important role for the cerebellum in the observed motor deficits in NF1. To test this, we determined the cerebellar contribution to motor problems in Nf1(+/-) mice, a validated mouse model for NF1. Using the Rotarod, a non-specific motor performance test, we confirmed that, like NF1 patients, Nf1(+/-) mice have motor deficits. Next, to evaluate the role of the cerebellum in these deficits, mice were subjected to cerebellum-specific motor performance and learning tests. Nf1(+/-) mice showed no impairment on the Erasmus ladder, as step time and number of missteps were not different. Furthermore, when compensatory eye movements were tested, no performance deficits were found in the optokinetic reflex and vestibulo-ocular reflex in the dark (VOR) or in the light (VVOR). Finally, Nf1(+/-) mice successfully completed short- and long-term VOR adaptation paradigms, tests that both depend on cerebellar function. Thus, despite the confirmed presence of motor performance problems in Nf1(+/-) mice, we found no indication of a cerebellar component. These results, combined with recent clinical data, suggest that cerebellar function is not overtly affected in NF1 patients.
© 2011 The Authors. Genes, Brain and Behavior © 2011 Blackwell Publishing Ltd and International Behavioural and Neural Genetics Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21352477     DOI: 10.1111/j.1601-183X.2011.00685.x

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  15 in total

Review 1.  Consensus paper: pathological role of the cerebellum in autism.

Authors:  S Hossein Fatemi; Kimberly A Aldinger; Paul Ashwood; Margaret L Bauman; Charles D Blaha; Gene J Blatt; Abha Chauhan; Ved Chauhan; Stephen R Dager; Price E Dickson; Annette M Estes; Dan Goldowitz; Detlef H Heck; Thomas L Kemper; Bryan H King; Loren A Martin; Kathleen J Millen; Guy Mittleman; Matthew W Mosconi; Antonio M Persico; John A Sweeney; Sara J Webb; John P Welsh
Journal:  Cerebellum       Date:  2012-09       Impact factor: 3.847

Review 2.  Treatment of neurodevelopmental disorders in adulthood.

Authors:  Eero Castrén; Ype Elgersma; Lamberto Maffei; Randi Hagerman
Journal:  J Neurosci       Date:  2012-10-10       Impact factor: 6.167

3.  Functional rescue in a mouse model of congenital muscular dystrophy with megaconial myopathy.

Authors:  Ambreen A Sayed-Zahid; Roger B Sher; Stacey J Sukoff Rizzo; Laura C Anderson; Kathryn E Patenaude; Gregory A Cox
Journal:  Hum Mol Genet       Date:  2019-08-15       Impact factor: 6.150

4.  HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1.

Authors:  A Omrani; T van der Vaart; E Mientjes; G M van Woerden; M R Hojjati; K W Li; D H Gutmann; C N Levelt; A B Smit; A J Silva; S A Kushner; Y Elgersma
Journal:  Mol Psychiatry       Date:  2015-04-28       Impact factor: 15.992

5.  Brain and behaviour phenotyping of a mouse model of neurofibromatosis type-1: an MRI/DTI study on social cognition.

Authors:  L I Petrella; Y Cai; J V Sereno; S I Gonçalves; A J Silva; M Castelo-Branco
Journal:  Genes Brain Behav       Date:  2016-07-05       Impact factor: 3.449

6.  Chronic Exposure to Tramadol Induces Neurodegeneration in the Cerebellum of Adult Male Rats.

Authors:  Samira Ezi; Mahdi Eskandarian Boroujeni; Aysan Khatmi; Kimia Vakili; Mobina Fathi; Mohammad-Amin Abdollahifar; Fakhroddin Aghajanpour; Reza Soltani; Seyed Hamidreza Mirbehbahani; Fariba Khodagholi; Abbas Aliaghaei; Reza Mastery Farahani
Journal:  Neurotox Res       Date:  2021-04-05       Impact factor: 3.911

7.  The effect of an mGluR5 inhibitor on procedural memory and avoidance discrimination impairments in Fmr1 KO mice.

Authors:  M F Vinueza Veloz; R A M Buijsen; R Willemsen; A Cupido; L W J Bosman; S K E Koekkoek; J W Potters; B A Oostra; C I De Zeeuw
Journal:  Genes Brain Behav       Date:  2012-01-19       Impact factor: 3.449

Review 8.  RASopathies: unraveling mechanisms with animal models.

Authors:  Granton A Jindal; Yogesh Goyal; Rebecca D Burdine; Katherine A Rauen; Stanislav Y Shvartsman
Journal:  Dis Model Mech       Date:  2015-08-01       Impact factor: 5.758

9.  Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.

Authors:  Edward Kim; Yuan Wang; Sun-Jung Kim; Miriam Bornhorst; Emmanuelle S Jecrois; Todd E Anthony; Chenran Wang; Yi E Li; Jun-Lin Guan; Geoffrey G Murphy; Yuan Zhu
Journal:  Elife       Date:  2014-12-23       Impact factor: 8.140

Review 10.  Skeletal muscle and motor deficits in Neurofibromatosis Type 1.

Authors:  M A Summers; K G Quinlan; J M Payne; D G Little; K N North; A Schindeler
Journal:  J Musculoskelet Neuronal Interact       Date:  2015-06       Impact factor: 2.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.